# FDA Inspection 1255220 - Fujian South Pharmaceutical Co. Ltd - October 11, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/fujian-south-pharmaceutical-co-ltd/b32cfc65-82e3-4060-96cf-a6e1bffac768
Source feed: FDA_Inspections

> FDA Inspection 1255220 for Fujian South Pharmaceutical Co. Ltd on October 11, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255220
- Company Name: Fujian South Pharmaceutical Co. Ltd
- Inspection Date: 2024-10-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1255220 - 2024-10-11](https://www.globalkeysolutions.net/records/fda_inspections/fujian-south-pharmaceutical-co-ltd/377232bc-bd85-4195-8e08-57d240ac03ad)
- [FDA Inspection 945573 - 2015-09-25](https://www.globalkeysolutions.net/records/fda_inspections/fujian-south-pharmaceutical-co-ltd/31027505-966b-46f9-8ac0-163a53cb7611)

Company: https://www.globalkeysolutions.net/companies/fujian-south-pharmaceutical-co-ltd/01bb8ccb-2d31-4854-8297-ff151db05e76

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c